Nuvalent, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$414.3M | -$280.4M | -$149.5M | -$86.1M | -$45.8M |
| Operating expenses | $414.3M | $280.4M | $149.5M | $86.1M | $45.8M |
| Cash from operations | -$275.2M | -$185.1M | -$99.7M | -$65.0M | -$40.0M |
| Total assets | $1.4B | $1.1B | $732.4M | $482.5M | $293.8M |
| Total liabilities | $164.4M | $72.0M | $31.8M | $19.5M | $8.8M |
Shares outstanding 79.0M · Free float 92.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.